Common Stock Issuance, Redeemable Common Stock, Common Stock Warrants, and Convertible Preferred Stock - Additional Information (Details)								1 Months Ended	3 Months Ended		6 Months Ended
	Mar. 31, 2025 USD ($) shares	Sep. 13, 2024 USD ($)	Sep. 11, 2024 USD ($) $ / shares shares	Aug. 20, 2024 shares	Feb. 25, 2024 USD ($) $ / shares shares	Feb. 17, 2023 USD ($) $ / shares shares	Sep. 17, 2020 $ / shares shares	Feb. 29, 2024 USD ($)	Jun. 30, 2025 USD ($) $ / shares shares	Jun. 30, 2024 USD ($)	Jun. 30, 2025 USD ($) $ / shares shares	Jun. 30, 2024 USD ($)	Mar. 13, 2025 $ / shares	Dec. 31, 2024 $ / shares shares	Mar. 31, 2023 USD ($) $ / shares shares
Subsidiary or Equity Method Investee [Line Items]
Offering expenses | $											$ 260,000	$ 0
Warrants outstanding									10,709,330		10,709,330			11,099,708
Warrants exercised (in shares)											(390,378)
Common stock, shares issued (in shares)									16,258,155		16,258,155			15,725,783
Common stock, par value (in dollars per share) | $ / shares									$ 0.0001		$ 0.0001			$ 0.0001
Proceeds from exercise of common stock warrants | $											$ 1,822,000	0
General and administrative | $									$ 7,228,000	$ 6,290,000	14,320,000	$ 12,340,000
Period for warrants to become exercisable after IPO							12 months
WTI Loan Facility | First Tranche Commitment | Term Loan
Subsidiary or Equity Method Investee [Line Items]
Proceeds from long-term borrowings | $											7,500,000
Remaining borrowing capacity | $	$ 2,500,000
Series A Convertible Preferred Stock
Subsidiary or Equity Method Investee [Line Items]
Redemption value | $									$ 11,479,000		$ 11,479,000
Preferred stock, shares issued (in shares)									11,479		11,479			11,479
Preferred stock, par value (in dollars per share) | $ / shares									$ 0.0001		$ 0.0001			$ 0.0001
Conversion of stock, shares converted (in shares)				15,721
Series B Convertible Preferred Stock
Subsidiary or Equity Method Investee [Line Items]
Warrants exercised (in shares)											0
Redemption value | $									$ 9,250,000		$ 9,250,000
Preferred stock, shares issued (in shares)									9,250		9,250			9,250
Preferred stock, par value (in dollars per share) | $ / shares									$ 0.0001		$ 0.0001			$ 0.0001
Warrants converted (in shares)											0
Common Class A
Subsidiary or Equity Method Investee [Line Items]
Shares issued upon conversion (in shares)				2,291,686
Redeemable Common Stock
Subsidiary or Equity Method Investee [Line Items]
Shares forfeited during the period (in shares)	62,500
Preferred stock, shares issued (in shares)									687,500		687,500			750,000
Titan Warrants
Subsidiary or Equity Method Investee [Line Items]
Warrants outstanding									125,405		125,405			125,405
Exercise price of warrant (in dollars per share) | $ / shares													$ 4.63
Warrants expiration period													5 years
Warrants exercised (in shares)											0
February 2023 Warrants
Subsidiary or Equity Method Investee [Line Items]
Exercise price of warrant (in dollars per share) | $ / shares						$ 4.66
Warrants exercised (in shares)											390,378
Common stock, shares issued (in shares)						7,871,712
Common stock, par value (in dollars per share) | $ / shares						$ 0.0001
Proceeds from issuance of preferred stock | $						$ 30,000,000
Number of securities called by each warrant (in shares)						1
February 2023 Warrants | Series A Convertible Preferred Stock
Subsidiary or Equity Method Investee [Line Items]
Preferred stock, shares issued (in shares)						30,000
Preferred stock, par value (in dollars per share) | $ / shares						$ 0.0001
Private Placement Warrants
Subsidiary or Equity Method Investee [Line Items]
Sale of number of warrants (in shares)							471,428
SBG Public Warrants
Subsidiary or Equity Method Investee [Line Items]
Warrants outstanding									821,428		821,428			821,428
Warrants expiration period									5 years		5 years
Warrants exercised (in shares)											0
SVB Warrants
Subsidiary or Equity Method Investee [Line Items]
Warrants outstanding									10,714		10,714			10,714
Exercise price of warrant (in dollars per share) | $ / shares															$ 5.32
Warrants exercised (in shares)											0
Number of securities called by warrants (in shares)															10,714
Value of warrants | $															$ 43,000
September 2024 Offering
Subsidiary or Equity Method Investee [Line Items]
Sale of stock, shares issued in transaction (in shares)			3,135,136
Sale of stock, price per share (in dollars per share) | $ / shares			$ 3.70
Consideration received | $			$ 10,590,000
Offering price discount to underwriter			0.07
Offering expenses | $											$ 863,000
Unpaid issuance costs | $									$ 0		$ 0
Reimbursement to underwriter of stock issuance costs | $		$ 198,000
Private Placement
Subsidiary or Equity Method Investee [Line Items]
Sale of stock, shares issued in transaction (in shares)			750,000
Private Placement | Series B Convertible Preferred Stock
Subsidiary or Equity Method Investee [Line Items]
Preferred stock, shares issued (in shares)					9,250
Preferred stock, par value (in dollars per share) | $ / shares					$ 0.0001
Common stock, shares issued (in shares)					1,799,021
Common stock, par value (in dollars per share) | $ / shares					$ 0.0001
Proceeds from issuance of preferred stock | $					$ 9,250,000			$ 9,250,000
Initial Public Offering | Public Shares
Subsidiary or Equity Method Investee [Line Items]
Units issued (in shares)							821,428
Initial Public Offering | Public Warrant
Subsidiary or Equity Method Investee [Line Items]
Exercise price of warrant (in dollars per share) | $ / shares							$ 161.00